Search results for "macula"

showing 10 items of 345 documents

Morphologische und funktionelle Ergebnisse nach transpupillarer Thermotherapie (TTT) maligner Aderhautmelanome

2006

BACKGROUND The aim of this study was to evaluate the course of tumor regression and visual impairment in choroidal melanomas treated by transpupillary thermotherapy (TTT) alone. PATIENTS AND METHODS In a prospective, non-randomized analysis 26 patients suffering from primary choroidal melanoma (posterior to the equator with base < or = 12 and thickness < or = 4.5 mm) were treated with the TTT standard protocol and followed for 33 - 45 months. Fluorescein and ICG angiographies were performed initially and after tumor regression clinically. RESULTS 22 tumors were significantly flattened after 1 - 3 TTT sessions. 4 tumors required additional therapy with ruthenium plaque. Visual acuity remaine…

medicine.medical_specialtyVisual acuitygenetic structuresmedicine.diagnostic_testbusiness.industryFluorescein angiographymedicine.diseaseeye diseasesSurgeryOphthalmologychemistry.chemical_compoundChoroidal neovascularizationchemistryOphthalmologyAngiographymedicinesense organsFluoresceinmedicine.symptomProspective cohort studybusinessIndocyanine greenMacular edemaKlinische Monatsblätter für Augenheilkunde
researchProduct

Kinetik von Indozyaningrün (ICG) und adjuvanter Einsatz zur transpupillaren Thermotherapie (TTT) pigmentarmer kleiner Aderhautmelanome

2004

BACKGROUND To determine the efficacy of intravenous indocyanine green (ICG) as an adjuvant to TTT for hypopigmented choroidal melanomas. PATIENTS AND METHODS ICG kinetics in melanoma tissue were evaluated by taking standardized ICG angiograms in 28 eyes with small choroidal melanomas. In a prospective non-randomized analysis 12 eyes with hypopigmented choroidal melanomas (posterior to the equator with thickness </= 4.5 mm) were treated with the TTT standard protocol developed by an intravenous injection of 100 mg ICG in 10 ml aqueous solvent 2 minutes after starting TTT. These eyes were followed-up for at least 22 months (mean 29). RESULTS Pharmacokinetic analyses revealed the onset of fluo…

medicine.medical_specialtyVisual acuitygenetic structuresmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentMelanomaeducationmedicine.diseaseeye diseasesSurgeryRadiation therapyOphthalmologychemistry.chemical_compoundchemistryOphthalmologyAngiographyTumor regressionStandard protocolMedicinesense organsmedicine.symptombusinessMacular edemaIndocyanine greenKlinische Monatsblätter für Augenheilkunde
researchProduct

Photodynamic Therapy in Subfoveal Choroidal Neovascularisation

2002

Summary The exudative form of age-related macular degeneration (AMD) is the leading cause of blindness among people over 50 years of age in the western world. In 2–10% of cases a subfoveal choroidal neovascularisation develops. Conventional laser treatment leads to an unspecific destruction of the CNV including adjacent retinal structures. In addition, significant and immediate vision loss occurs, particularly in cases with central, subfoveal localization of the CNV.Photodynamic therapy (PDT) employing photochemical activation of verteporfin as a photosensitizer induces selective occlusion of CNV with minimal damage to the neurosensory retina and does not impair visual acuity. It became ava…

medicine.medical_specialtyVisual acuitygenetic structuresmedicine.medical_treatmentPhotodynamic therapyDermatologychemistry.chemical_compoundOphthalmologyOcclusionmedicineRetinabusiness.industryLaser treatmentRetinalMacular degenerationmedicine.diseaseVerteporfineye diseasesSurgerymedicine.anatomical_structurechemistrySurgerysense organsmedicine.symptombusinessmedicine.drugMedical Laser Application
researchProduct

Intravitreal Dexamethasone Implant for Postoperative Macular Oedema Secondary to Vitrectomy for Epiretinal Membrane and Retinal Detachment: A Systema…

2021

Purpose. To evaluate the efficacy of intravitreal dexamethasone implant (DEX) for the treatment of macular oedema secondary to vitrectomy for epiretinal membrane (ERM) and retinal detachment (RD) by conducting a systematic review with meta-analysis of published studies. Methods. Studies reporting clinical outcomes of DEX use for the treatment of macular oedema secondary to ERM and RD vitrectomy were searched on PubMed and Embase databases. The primary outcome was best-corrected visual acuity (BCVA) change between baseline and post-DEX treatment, reported as mean difference (MD) with 95% confidence interval (CI). Mean central macular thickness (CMT) change was assessed as a secondary outcome…

medicine.medical_specialtyVisual acuitygenetic structuresmedicine.medical_treatmentPopulationVitrectomyReview Articlelaw.inventionRandomized controlled triallawOphthalmologymedicineeducationDexamethasoneeducation.field_of_studybusiness.industryRetinal detachmentRE1-994medicine.diseaseConfidence intervalmacular oedema intravitreal dexamethasone implant (DEX) vitrectomy epiretinal membrane (ERM) retinal detachment (RD).OphthalmologyEpiretinal membranemedicine.symptombusinessmedicine.drug
researchProduct

Urgent Vitrectomy with Vancomycin Infusion, Silicone Oil Endotamponade, and General Antibiotic Treatment in Multiple Cases of Endophthalmitis from a …

2021

The aim of this study was to report on the anatomical and functional results of surgical management of seven cases of endophthalmitis related to a single day of intravitreal aflibercept injections. Patients with signs of endophthalmitis who underwent aflibercept injections (seven eyes) performed on the same day were retrospectively evaluated. The data of visual acuity and optical coherence tomography (OCT) within nine months of the follow-up and the treatment and results of microbiological cultures are reported. Four of the total seven cases had a positive bacterial culture outcome (Streptococcus mitis). All patients underwent vitrectomy combined with phacoemulsification when the eyes were …

medicine.medical_specialtyVisual acuitygenetic structuresmedicine.medical_treatmentlcsh:MedicineVitrectomyBacterial endophthalmitiArticle03 medical and health sciences0302 clinical medicineEndophthalmitisOphthalmologymedicinepost-injection endophthalmitis030212 general & internal medicineAfliberceptendophthalmitis treatmentbusiness.industrylcsh:Rbacterial endophthalmitisGeneral MedicinePhacoemulsificationMacular degenerationmedicine.disease<i>Streptococcus mitis/oralis</i>eye diseasesStreptococcus mitis/oralis030221 ophthalmology & optometryVancomycinTamponadeBacterial endophthalmitis; En-dophthalmitis treatment; Post-injection endophthalmitis; Streptococcus mitis/oralissense organsmedicine.symptomPost-injection endophthalmitiEn-dophthalmitis treatmentbusinessmedicine.drugJournal of Clinical Medicine
researchProduct

Incidence and Risk Factors for Tractional Macular Detachment after Anti-Vascular Endothelial Growth Factor Agent Pretreatment before Vitrectomy for C…

2019

The study&rsquo

medicine.medical_specialtyYounger agegenetic structuresmedicine.medical_treatmentvitrectomyVitrectomytractional macular detachmentArticle03 medical and health sciences0302 clinical medicineOphthalmologymedicine030212 general & internal medicineanti-VEGF; proliferative diabetic retinopathy; tractional macular detachment; vitrectomyAnti vegfbusiness.industryPrimary vitrectomyIncidence (epidemiology)General MedicineDiabetic retinopathymedicine.diseaseeye diseasesMacular detachmentanti-VEGFVitreous hemorrhage030221 ophthalmology & optometrysense organsbusinessproliferative diabetic retinopathyJournal of Clinical Medicine
researchProduct

Use in clinical practice of an automated screening method of diabetic retinopathy that can be derived using a diagnostic artificial intelligence syst…

2020

Abstract Background and Objective To compare the diagnostic performance of an autonomous diagnostic artificial intelligence (AI) system for the diagnosis of derivable diabetic retinopathy (RDR) with manual classification. Materials and Methods Patients with type 1 and type 2 diabetes participated in a diabetic retinopathy (RD) screening program between 2011–2012. 2 images of each eye were collected. Unidentifiable retinal images were obtained, one centered on the disc and one on the fovea. The exams were classified with th e autonomous AI system and manually by anonymous ophthalmologists. The results of the AI system and manual classification were compared in terms of sensitivity and specif…

medicine.medical_specialtybusiness.industry030209 endocrinology & metabolismGeneral MedicinePrimary careDiabetic retinopathyType 2 diabetesmedicine.diseaseDecreased visionClinical Practice03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitus030221 ophthalmology & optometryScreening methodmedicinebusinessMacular edemaArchivos de la Sociedad Española de Oftalmología (English Edition)
researchProduct

Vision-related function in the COPERNICUS and GALILEO trials

2014

Purpose To examine the impact of intravitreal aflibercept (IVT-AFL) injection on the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ) in the COPERNICUS and GALILEO trials. Methods Patients (pts) with macular oedema secondary to central retinal vein occlusion received IVT-AFL 2 mg (IVT-AFL 2q4) or sham monthly for 24 weeks. After Week 24 (W24) in COPERNICUS all pts were eligible to receive IVT-AFL based on visual and anatomical outcomes (IVT-AFL 2q4+PRN, sham+IVT-AFL PRN). In GALILEO, sham-treated pts received sham tx until W52. The NEI VFQ was administered at baseline (BL), W24 and W52. Total and subscale scores were compared between groups. W24 data were integrated an…

medicine.medical_specialtybusiness.industryMacular oedemaGeneral Medicinemedicine.diseaseSurgerySham groupOphthalmologyCentral retinal vein occlusionVisual functionOphthalmologymedicineGalileo (vibration training)businessAfliberceptmedicine.drugActa Ophthalmologica
researchProduct

The LDL receptor in the retina: the missing link in aging, the new target in dietary prevention

2012

National audience; Purpose: The discovery of the LDL receptor (LDLR) in 1985 by Brown and Goldstein was awarded by a Nobel Prize. The LDLR has initially been identified for its role in mediating the endocytosis of LDL particles in the vascular endothelium. The deposition of lipids, including cholesterol and cholesteryl esters in Bruch’s Membrane in the one hand, and in the vessel intima in the other hand, is one of the common features of age related macular degeneration (AMD) and cardiovascular disease (CVD). Dietary habits with high intakes of omega 3 long chain fatty acids (LCFA) have been associated with AMD prevention. Similar effects have been demonstrated in CVD prevention. The mechan…

medicine.medical_specialtygenetic structures030309 nutrition & dieteticsLinoleic acidEndocytosis03 medical and health scienceschemistry.chemical_compound0404 agricultural biotechnologyInternal medicineGene expressionmedicinecardiovascular diseases[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs0303 health sciencesRetinaCholesterolbusiness.industry04 agricultural and veterinary sciencesGeneral MedicineMacular degenerationmedicine.disease040401 food scienceeye diseases3. Good healthOphthalmologyEndocrinologymedicine.anatomical_structurechemistryHumanized mouseLDL receptorlipids (amino acids peptides and proteins)sense organsbusiness[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study

2011

The purpose of this study was to evaluate the effectiveness of intravitreal ranibizumab (Lucentis, Genentech, South San Francisco, Calif, USA) combined with cataract surgery for the prevention of clinically significant macular edema (CSME) in patients with diabetic retinopathy (DR). This prospective interventional case series included fifty-four eyes of 54 patients with a previous diagnosis of nonproliferative diabetic retinopathy (NPDR) without macular edema preoperatively. Subjects were assigned in a 1 : 1 ratio to receive an intraoperative intravitreal ranibizumab injection (n=27) or not (control group,n=27) associated with standardised phacoemulsification surgery. The main outcome measu…

medicine.medical_specialtygenetic structuresArticle Subjectbusiness.industrymedicine.medical_treatmentIncidence (epidemiology)After cataractPhacoemulsificationDiabetic retinopathyCataract surgerymedicine.diseaseeye diseasesSurgeryOphthalmologylcsh:Ophthalmologylcsh:RE1-994OphthalmologymedicineClinical StudyIn patientIntravitreal ranibizumabbusinessMacular edemaJournal of Ophthalmology
researchProduct